ESPR CLEAR Outcomes Data Finally Here!
First published 3/6/23 - currently in progress Summary: ESPR CLEAR outcomes data from NEXLETOL trial reported over the weekend at ACC.23...
${alertText}
Want unlimited access? Try Pro free for 7 days.
ESPR CLEAR Outcomes Data Finally Here!
Weekly Biotech Catalyst Watchlist Q1 2023
Biopharma Pulse - 2/27-3/3 Weekly Review
Available Oncology Investor Conference Webcasts
10 Rare Disease Catalysts to Watch
Weekly Biotech Catalyst Watchlist Feb/March
Big/Suspected Movers FAQ/User Guide
Quarterly Big Mover Biotech Stocks To Watch
Q2 2023 Product Revenue Analyses
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
SYFOVRE (APLS) vs. IZERVAY (Astellas)
BIIB & SAGE: Zuranolone
Apellis Pharmaceuticals (APLS)
Our platform helps you uncover your next biotech investment opportunity